Non-linearity of dosing and pharmacokinetics

I'm trying to figure out how to draft three standalone bits of content all tied to one central theme.

You're asking about randomized controlled trials on people, right? Some work without controls has turned up, but I share the view that no proper RCTs exist.

I agree that combining things can be unpredictable, and with all the possible mixes out there, it's unlikely we'll see research covering each one, given how they multiply exponentially. That particular effect between those compounds was news to me.

I noted before that GLP-1 is an instance where you see less improvement with more use.

Rereading your message made me realize you cited those compounds only to show how gains decrease eventually, without implying any kind of reversal would occur. I overlooked the exact precision in your choice of words initially.

I'm wondering about different ways to measure out and schedule these compounds like MOTS-C, Melanotan-2, SS-31, NAD+ and Epitalon. I've been checking into them for my own upcoming experiments, yet all the studies I've seen along with personal stories still show a broad range of options for amounts and timings. Would you mind adding your input, whether it backs up or challenges what's already circulating, as I'd like to know more.

I'm also seeing conflicting details on combining CJC without DAC alongside the Tesamorelin and Ipamorelin combination. A few mention it might overload or reduce sensitivity in the receptors, yet others suggest they might work well together based on how much is used, or that separating the times like morning for one pair and evening for the other could help. I'd like to hear opinions on this discussion too, haha. Appreciate any input shared!

Appreciate the post and curious about upcoming subjects here. Lately I've pondered methods to gauge personal duration of action along with suitable intake amounts for these treatments, linking to the points raised. Take someone I know facing extra medical concerns such as an immune disorder who uses a modest regular amount of the medication. This person shows an intense reaction with periods of complete inability to keep food down or feeling severe unease. A prior similar treatment produced matching effects. The strength proved excessive for reducing weight resulting in an extremely lean appearance yet without peers for reference she accepted it as typical and made no changes. Perhaps sensitivity calls for smaller intake but the other conditions could slow removal extending the time in the system substantially. Fixed delivery devices limit options for tweaks while a container permitting finer adjustments to both quantity and timing creates a puzzle around finding equilibrium. How might one best check actual duration and suitable level to weigh benefits against unwanted effects? Some people could process the substance quicker making more frequent modest intakes preferable over larger ones. It's interesting to consider.

Are you talking about combining every one of those? I lack detailed knowledge on each beyond studying them in school so consider what I say next cautiously. I would recommend checking further on the effectiveness of NAD+. As far as I know there isn't a confirmed way for cells to transport NAD+ directly. Introducing NAD+ directly into the veins requires it to be broken down into building blocks like nicotinamide or nicotinamide riboside so that cells can actually utilize it. I've been looking at MOTS-C lately. By the way a clinical study in early stages used daily shots under the skin of a similar version with the main focus on liver fat issues and it showed better results though skin reactions at the injection spot happened often. Epitalon catches my attention. It looks like it offers remarkable advantages regarding lifespan and chromosome end lengths yet every bit of evidence originates from a single research group in old USSR. Still a recent investigation managed to copy those findings which is encouraging. Those advantages seem overly optimistic. Maybe they don't fully apply to people so we can't tell without others experimenting with various amounts.

This thread shows exactly why dosing should be tailored to the individual. Concepts around managing pain relief through gradual adjustments might transfer over to these compounds as well. With enough people now using various options, group efforts could help figure out whether response patterns depend on basic personal traits or simple observable characteristics. Figuring out the best way to determine real duration in the body looks like a math challenge, and it's an area I've been exploring lately with plans to post findings shortly.

Appreciate the reply and the distinction you made. I was thinking of separate use rather than combined, though combining later still sounds fine once I know more about each one on its own. The detail on that trial dose range caught my attention since I had seen suggestions running from 2 mg three times a week up to 5 mg five times a week. Learning they used 25 mg every day in the actual study takes away some hesitation I felt about the upper side of those numbers. Reactions at the injection spot keep coming up no matter the amount. Any chance you have references or overviews for the Epitalon work? Otherwise I can look on my own, mainly to see the amounts tested and what came out of it. With the other one my biggest uncertainty is whether worries about kidney harm or other major problems are actually justified. Thanks again for taking the time to lay out your thoughts.

Epitalon really impressed me following my latest twenty day regimen. Daily intake came to one milligram through the nasal passage. Age together with an earlier head injury led me to look into its reported ability to restore normal neural messaging and activity. Several discussions on this site show interest in trying it out. The newest papers that seem relevant struck me as quite interesting. They pushed the substance higher on my priorities once I started another compound.

I've got reserves of bpc 157 and tb 500 around for whenever an unexpected need pops up.

In all honesty the dad probably turned out responsible for the whole thing.

Appreciate you sharing the good update regarding that research on epithalon showing the same outcomes again. Never stumbled upon it no matter how much I looked. Could you share the document or its contents somehow? The area fascinates me a lot. Always figured folks adjust doses gradually until they notice changes, accepting smaller gains since bigger ones aren't simple to get otherwise. With milder acting compounds, fake improvements might hide what higher amounts actually do. Got any solid cases where effects reversed? Or peptides you think behave like that?

Wow, this is spot on! Right now I'm using the smallest possible amount of Epitalon, just half a milligram each time, since I need to stretch out my single bottle. Thanks to that, my nighttime rest is better than ever. After such a long period, I finally appear and sense that I've had proper recovery, and my nighttime visions come back to me so sharply. Grateful for those fascinating papers to check out. 🙏

I came across some research on epitalon that seems relevant. With melanotan two, people have mentioned kidney problems as a possible reaction, though supposedly only when larger amounts get used. My own knowledge on the topic stays pretty limited. A couple of key articles exist that cover related details.

Yeah that checks out, I'll remember your comment down the road.

Grateful for the tip. I'll examine those soon enough.

Sure, here it is. The product they're referring to in the update is basically modeled on the MOTS-C peptide.

This peptide really stands out to me. It falls into that category of substances whose benefits sound almost impossible. Yet basically every study traces back to one particular facility in that city.

I spotted a couple of articles that worked well when checking dosage effects. Their main focus wasn't on that aspect yet they compared shifts in key results for three separate treatment schedules.

I mentioned another instance earlier in the thread. Nothing newer had come to my attention. It would be good if they persisted with thorough studies regarding this topic.

Certain papers among those can be accessed by me. I am making an effort to examine several. Yet research performed in nations where political factors shape scientific progress tends to complicate assessments of its impartiality. I possess no particular details regarding the situation at hand, but I recall that numerous widely publicized medical investigations from East Germany failed to be accurately depicted.

Both of us mentioned a study carried out over in Britain and I've attached the complete paper right here.

The investigation into lengthening telomeres using cell cultures happened over in Britain. I had been considering those investigations into extending lifespan with specific compounds across several years. One such effort with people lasted six years and indicated the death rate dropped substantially among the participants who received the regimen. It makes me question straight away whether the treated participants were the survivors or if missing data from dropouts skewed things. I've noticed this kind of mix-up in interpreting what caused what in other work on lingering effects after viral infections. They might have handled the details properly, yet having access to more than just the summary would increase my trust in the findings. Information on compounds from certain glands showed they can help people live longer, with results backing their value in reducing aging problems and supporting health in older adults to keep them active longer.